Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells-Reference-Cited by-同舟云学术

Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells

Published:2016-08 Issue: Volume:47 Page:100-108
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Valdez Benigno C.^ORCID,Brammer Jonathan E.,Li Yang,Murray David,Teo Esmeralda C.,Liu Yan,Hosing Chitra,Nieto Yago,Champlin Richard E.,Andersson Borje S.

Funder

National Institutes of Health

Stephen L

Lavinia Boyd

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference31 articles.

1. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993);Marks;Blood,2009

2. Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia;Bakr;Biol. Blood Marrow Transplant.,2012

3. Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma;Smith;J. Clin. Oncol.,2013

4. Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study;Krishnan;Brit. J. Haematol.,2010

5. Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sezary syndrome: a European society for blood and marrow transplantation lymphoma working party extended analysis;Duarte;J. Clin. Oncol.,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells;Frontiers in Oncology;2023-11-23

2. Therapeutic approaches for relapsed/refractory adult acute lymphoblastic leukemia (ALL), a review on monoclonal antibodies and targeted therapies;Indian Journal of Cancer;2022-01

3. Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma;British Journal of Cancer;2020-05-11

4. Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells;Oncotarget;2017-12-17

5. The discovery and development of romidepsin for the treatment of T-cell lymphoma;Expert Opinion on Drug Discovery;2017-06-22